219 related articles for article (PubMed ID: 11785773)
21. Vasopressin and oxytocin regulation of cyclic AMP accumulation in rat hypothalamo-neurohypophysial explants in vitro.
Meeker RB; Michels KM; Hayward JN
Neurosci Lett; 1990 Jul; 114(2):225-30. PubMed ID: 2168530
[TBL] [Abstract][Full Text] [Related]
22. Effects of centrally or systemically injected glucagon-like peptide-1 (7-36) amide on release of neurohypophysial hormones and blood pressure in the rat.
Bojanowska E; Stempniak B
Regul Pept; 2000 Jul; 91(1-3):75-81. PubMed ID: 10967203
[TBL] [Abstract][Full Text] [Related]
23. Vasopressin release from the rat hypothalamo-neurohypophysial system: effects of gonadotrophin-releasing hormone (GnRH), its analogues and melatonin.
Boczek-Leszczyk E; Stempniak B; Juszczak M
J Physiol Pharmacol; 2010 Aug; 61(4):459-66. PubMed ID: 20814074
[TBL] [Abstract][Full Text] [Related]
24. The role of steroid hormones in the regulation of vasopressin and oxytocin release and mRNA expression in hypothalamo-neurohypophysial explants from the rat.
Sladek CD; Swenson KL; Kapoor R; Sidorowicz HE
Exp Physiol; 2000 Mar; 85 Spec No():171S-177S. PubMed ID: 10795920
[TBL] [Abstract][Full Text] [Related]
25. Effect of melatonin on the vasopressin secretion as influenced by tachykinin NK-1 receptor agonist and antagonist: in vivo and in vitro studies.
Juszczak M; Boczek-Leszczyk E; Stempniak B
J Physiol Pharmacol; 2007 Dec; 58(4):829-43. PubMed ID: 18195491
[TBL] [Abstract][Full Text] [Related]
26. The role of melatonin membrane receptors in melatonin-dependent oxytocin secretion from the rat hypothalamo-neurohypophysial system - an in vitro and in vivo approach.
Juszczak M; Wolak M; Bojanowska E; Piera L; Roszczyk M
Endokrynol Pol; 2016; 67(5):507-514. PubMed ID: 26884304
[TBL] [Abstract][Full Text] [Related]
27. The role of the cAMP/PKA signalling pathway in the inhibitory influence of melatonin on oxytocin and vasopressin secretion from the rat hypothalamo-neurohypophysial system.
Juszczak M; Krzyminska A; Bojanowska E; Roszczyk M
Endokrynol Pol; 2018; 69(5):560-566. PubMed ID: 30074234
[TBL] [Abstract][Full Text] [Related]
28. Thyrotropin-releasing hormone (TRH) inhibits vasopressin and oxytocin release from rat hypothalamo-neurohypophysial explants in vitro.
Ciosek J; Stempniak B
Acta Neurobiol Exp (Wars); 1996; 56(1):35-40. PubMed ID: 8787195
[TBL] [Abstract][Full Text] [Related]
29. Influence of thyroliberin (TRH) on hypothalamo-neurohypophysial vasopressin and oxytocin content of rats drinking 2% NaCl.
Ciosek J
Patol Pol; 1993; 44(4):221-6. PubMed ID: 8309734
[TBL] [Abstract][Full Text] [Related]
30. The hepatic vagal reception of intraportal GLP-1 is via receptor different from the pancreatic GLP-1 receptor.
Nishizawa M; Nakabayashi H; Kawai K; Ito T; Kawakami S; Nakagawa A; Niijima A; Uchida K
J Auton Nerv Syst; 2000 Apr; 80(1-2):14-21. PubMed ID: 10742535
[TBL] [Abstract][Full Text] [Related]
31. Vasopressin and oxytocin release and the thyroid function.
Ciosek J; Drobnik J
J Physiol Pharmacol; 2004 Jun; 55(2):423-41. PubMed ID: 15213363
[TBL] [Abstract][Full Text] [Related]
32. Glucagon-like peptide-1-(7-36) amide, oxyntomodulin, and glucagon interact with a common receptor in a somatostatin-secreting cell line.
Gros L; Thorens B; Bataille D; Kervran A
Endocrinology; 1993 Aug; 133(2):631-8. PubMed ID: 8102095
[TBL] [Abstract][Full Text] [Related]
33. Immunocytochemical localization of chromogranin A in the normal and stimulated hypothalamo-neurohypophysial system of the rat.
Majdoubi ME; Metz-Boutigue MH; Garcia-Sablone P; Theodosis DT; Aunis D
J Neurocytol; 1996 Jul; 25(7):405-16. PubMed ID: 8866241
[TBL] [Abstract][Full Text] [Related]
34. Oxytocin and vasopressin secretion from the rat hypothalamo-neurohypophysial system is stimulated by triptorelin.
Juszczak M; Roszczyk M
Endokrynol Pol; 2012; 63(3):176-81. PubMed ID: 22744622
[TBL] [Abstract][Full Text] [Related]
35. The effect of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') and its metabolites on neurohypophysial hormone release from the isolated rat hypothalamus.
Forsling ML; Fallon JK; Shah D; Tilbrook GS; Cowan DA; Kicman AT; Hutt AJ
Br J Pharmacol; 2002 Feb; 135(3):649-56. PubMed ID: 11834612
[TBL] [Abstract][Full Text] [Related]
36. Galanin influences on vasopressin and oxytocin release: in vitro studies.
Izdebska K; Ciosek J
Neuropeptides; 2010 Aug; 44(4):341-8. PubMed ID: 20466422
[TBL] [Abstract][Full Text] [Related]
37. The hypothalamic and neurohypophysial vasopressin and oxytocin content under various states of adrenergic transmission in dehydrated and subsequently rehydrated rats.
Ciosek J; Guzek JW; Morawska J
Acta Physiol Pol; 1985; 36(4):229-41. PubMed ID: 3019081
[TBL] [Abstract][Full Text] [Related]
38. Atrial natriuretic peptide inhibits neurohypophysial hormones' release in the rat (in vitro and in vivo studies).
Lewandowska A; Szyburska I; Guzek JW
J Physiol Pharmacol; 1992 Mar; 43(1):79-88. PubMed ID: 1450436
[TBL] [Abstract][Full Text] [Related]
39. The hypothalamic and neurohypophysial vasopressor and oxytocic content as influenced by alpha-adrenergic blockade in stressed rats.
Guzek JW; Olczak S; Lewandowska A
Acta Physiol Pol; 1985; 36(3):193-200. PubMed ID: 3017050
[TBL] [Abstract][Full Text] [Related]
40. Cholecystokinin octapeptide and the daily rhythm of vasopressin and oxytocin release.
Morawska-Barszczewska J; Guzek JW; Kaczorowska-Skóra J
Exp Clin Endocrinol Diabetes; 1996; 104(2):164-71. PubMed ID: 8740941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
